We rank companies based on fund manager, research analyst and news sentiment
ADXN

Addex Therapeutics Ltd American Depositary Shares
ADXN

$25.02
2.13%
 

About: Addex Therapeutics Ltd is a biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe.

Employees: 24

0
Funds holding %
of 6,474 funds
Analysts bullish %
News positive %

Fund manager confidence

Based on 2023 Q4 SEC filings by fund managers ($100M+ AUM)

15% more capital invested

Capital invested by funds: $625K [Q3] → $717K (+$91.7K) [Q4]

0.45% less ownership

Funds ownership: 0.54% [Q3] → 0.09% (-0.45%) [Q4]

40% less funds holding

Funds holding: 5 [Q3] → 3 (-2) [Q4]

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Research analyst outlook

We haven’t received any recent analyst ratings for ADXN.

Financial journalist opinion